These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34784462)
21. Models to evaluate the barrier properties of mucus during drug diffusion. Liu L; Tian C; Dong B; Xia M; Cai Y; Hu R; Chu X Int J Pharm; 2021 Apr; 599():120415. PubMed ID: 33647411 [TBL] [Abstract][Full Text] [Related]
22. Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies. Abdulkarim M; Sharma PK; Gumbleton M Adv Drug Deliv Rev; 2019 Mar; 142():62-74. PubMed ID: 30974131 [TBL] [Abstract][Full Text] [Related]
23. Impact of Mucin on Drug Diffusion: Development of a Straightforward in Vitro Method for the Determination of Drug Diffusivity in the Presence of Mucin. Falavigna M; Stein PC; Flaten GE; di Cagno MP Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32079348 [TBL] [Abstract][Full Text] [Related]
24. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958 [TBL] [Abstract][Full Text] [Related]
25. Undefined role of mucus as a barrier in ocular drug delivery. Ruponen M; Urtti A Eur J Pharm Biopharm; 2015 Oct; 96():442-6. PubMed ID: 25770770 [TBL] [Abstract][Full Text] [Related]
26. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it? Pearson JP; Chater PI; Wilcox MD Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985 [TBL] [Abstract][Full Text] [Related]
27. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption. Boegh M; Baldursdóttir SG; Müllertz A; Nielsen HM Eur J Pharm Biopharm; 2014 Jul; 87(2):227-35. PubMed ID: 24413146 [TBL] [Abstract][Full Text] [Related]
28. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium. Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730 [TBL] [Abstract][Full Text] [Related]
29. Intestinal mucus barrier: a missing piece of the puzzle in food allergy. Parrish A; Boudaud M; Kuehn A; Ollert M; Desai MS Trends Mol Med; 2022 Jan; 28(1):36-50. PubMed ID: 34810087 [TBL] [Abstract][Full Text] [Related]
30. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer. Loftsson T Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564 [TBL] [Abstract][Full Text] [Related]
31. Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung. Chen D; Liu J; Wu J; Suk JS Expert Opin Drug Deliv; 2021 May; 18(5):595-606. PubMed ID: 33218265 [No Abstract] [Full Text] [Related]
32. Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers. Ahmed TA; Bawazir AO; Alharbi WS; Safo MK Int J Nanomedicine; 2020; 15():4001-4020. PubMed ID: 32606661 [TBL] [Abstract][Full Text] [Related]
33. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties. Boegh M; Nielsen HM Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):179-86. PubMed ID: 25349046 [TBL] [Abstract][Full Text] [Related]
34. Simultaneous assessment of in vitro lipolysis and permeation in the mucus-PVPA model to predict oral absorption of a poorly water soluble drug in SNEDDSs. Falavigna M; Brurok S; Klitgaard M; Flaten GE Int J Pharm; 2021 Mar; 596():120258. PubMed ID: 33486034 [TBL] [Abstract][Full Text] [Related]
36. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability. Falavigna M; Klitgaard M; Steene E; Flaten GE Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502 [TBL] [Abstract][Full Text] [Related]
37. Purified mucins in drug delivery research. Marczynski M; Kimna C; Lieleg O Adv Drug Deliv Rev; 2021 Nov; 178():113845. PubMed ID: 34166760 [TBL] [Abstract][Full Text] [Related]
38. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease. Fernández-Tomé S; Ortega Moreno L; Chaparro M; Gisbert JP Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638564 [TBL] [Abstract][Full Text] [Related]
39. Development of Self-Emulsifying Drug Delivery Systems (SEDDSs) Displaying Enhanced Permeation of the Intestinal Mucus Following Sustained Release of Prototype Thiol-Based Mucolytic Agent Load. Malkawi A; Alrabadi N; Haddad R; Malkawi A; Khaled K; Ovenseri AC Molecules; 2022 Jul; 27(14):. PubMed ID: 35889482 [TBL] [Abstract][Full Text] [Related]
40. A slippery slope: On the origin, role and physiology of mucus. Taherali F; Varum F; Basit AW Adv Drug Deliv Rev; 2018 Jan; 124():16-33. PubMed ID: 29108861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]